Erik Harris is a director of Denali Therapeutics Inc.
Person profile
Roles
Address
Novato, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Ultragenyx Pharmaceutical Inc.
5 Mar 24
4
Ultragenyx Pharmaceutical Inc.
6 Sep 23
144
Ultragenyx Pharmaceutical Inc.
5 Sep 23
4
Ultragenyx Pharmaceutical Inc.
21 Jun 23
4
Denali Therapeutics Inc.
5 Jun 23
4
Ultragenyx Pharmaceutical Inc.
3 Mar 23
4
Ultragenyx Pharmaceutical Inc.
22 Jun 22
4
Ultragenyx Pharmaceutical Inc.
3 Mar 22
3/A
Denali Therapeutics Inc.
14 Feb 22
4
Denali Therapeutics Inc.
7 Feb 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 53.76 | 4,768 | 256.33 k | 67,163 |
1 Mar 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 957 | 0.00 | 71,638 |
1 Mar 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 19,400 | 0.00 | 70,681 |
1 Mar 24 | RARE Ultragenyx Pharmaceutical | Stock Option Common Stock | Grant | Acquire A | No | No | 53.69 | 34,200 | 1.84 mm | 34,200 |
5 Sep 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 37.96 | 6,000 | 227.76 k | 51,281 |
19 Jun 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 48.2 | 305 | 14.70 k | 57,281 |
1 Jun 23 | DNLI Denali Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 4,216 | 0.00 | 11,085 |
1 Jun 23 | DNLI Denali Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 30.92 | 12,649 | 391.11 k | 12,649 |
1 Mar 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 45.25 | 3,664 | 165.80 k | 57,344 |
1 Mar 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 22,000 | 0.00 | 60,823 |